- Kits, Reagents, and Consumables
- Filtration Systems
- Services
Virus Filtration Market is estimated to be valued at USD 2,978.3 Mn in 2021, It is growing at a significant CAGR of 12.1% from 2022-2028. Growth in the biopharmaceutical industry, rising prevalence of chronic diseases including cancer, diabetes, etc, acceptance of single-use technologies, increase in therapeutics contamination by viruses, favorable government support, and increasing R&D spending are some key factors fostering the market growth. However, factors such as strict government regulations is the major factor hindering market growth. Further, growth in emerging economies provides a huge opportunity for market growth. this market is surging owing to frequent acquisitions and launchings by the market players. For Instance, in August 2015, Danaher Corporation acquired Pall Corporation, a leading provider of virus filtration products. This report gives a comprehensive outlook on virus filtration across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of product, application, end-user, and region. This report studies global virus filtration market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the global virus filtration market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the global virus filtration market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global virus filtration market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global virus filtration products.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The burden of chronic diseases is quickly growing worldwide. Nearly half of the total chronic disease deaths are attributable to cardiovascular diseases, obesity and diabetes are also presenting upsetting trends, not only because they already affect a large proportion of the population, but also because they have started to appear earlier in life. Factors such as the increasing prevalence of chronic diseases are contributing to the growth of the market. The increasing prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders, are anticipated to propel the demand for biologics. Growing adoption of advanced viral removal products has been observed for the development and production of innovative therapeutics for the treatment of chronic diseases.
The virus filtration market is projected to expand at a CAGR of 12.1% during the forecast period.
Asahi Kasei Medical Co. Ltd,Charles River Laboratories International Inc.,Clean Cell Inc.,Danaher Corporation (Pall Corporation), General Electric Company, Lonza Group Ltd
North America is the fastest-growing region for virus filtration market
[urltag url='request-table-of-content']